Clinical trial
TCF7L2 Polymorphisms Influence on Glycemic Control in ICU Patients With Organ Failure
NCT03055169 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TCF7L2 Polymorphisms Influence on Glycemic Control in ICU Patients With Organ Failure
- Lead sponsor
- University Hospital, Lille
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2012
- Completion date
- August 31, 2017
- Enrollment
- 994 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
genetic predisposition to disease, hyperglycemia, intensive care unit syndrome, multiple organ failure